Article Text
PDF
Statistics from Altmetric.com
OpenUrlAbstract/FREE Full Text
Q Is escitalopram more effective than paroxetine or placebo for people with generalised anxiety disorder?
METHODS
Design:
Randomised controlled trial.
Allocation:
Concealed.
Blinding:
Double blind.
Follow-up period:
Twelve weeks (treatment period).
Setting:
Sixty three centres in 10 countries; time period not stated.
Patients:
681 people with generalised anxiety disorder (DSM-IV-TR; aged 18–65 years; 64% female), Hamilton Anxiety Scale (HAMA) total score ⩾20, and HAMA anxious mood and tension items scores ⩾2. Exclusions: DSM-IV-TR major depressive, panic, social anxiety, post-traumatic stress, bipolar, obsessive-compulsive, eating, body dysmorphic, substance misuse or personality disorders in the last 6 months; current or previous DSM-IV-TR psychotic disorder; suicidal; cognitive-behavioural, electroconvulsive, cognitive or problem solving therapy; other serious medical condition; …
Footnotes
For correspondence: David S Baldwin, University Department of Mental Health, Royal South Hants Hospital, Graham Road, Southampton SO14 0YG, UK; dsbl{at}soton.ac.uk
Source of funding: Lundbeck A/S, Denmark.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.